US5104641A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Nitroxide NMR contrast enhancing agents and their use in NMR imaging
Assignee: NITROSCI MEDICAL PRODUCTS LLC
•
Filing: 1990-02-26
•
Granted: 1992-04-14
•
Expires: 2010-02-26
Abstract
Abstract Nitroxides useful as NMR contrast enhancing agents for organs are of the formula ##STR1## wherein in the above formulae, R 1 , R 2 , R 3 and R 4 are, g., CH 3 ; R is --B--COO--M + or --B--N(alkyl) 3 Hal - , wherein B is a divalent bond or alkylene of 1-8 carbon atoms, M is an ammonium or metal ion and Hal is a halogen atom; are also useful as NMR contrast enhancing agents on joints.
Inventors
- 👤 Gerald M. Rosen
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-10 02:35
CPC Classifications
G; G01; G01R; G01R33/00; G01R33/20; G01R33/44; G01R33/48; G01R33/54; G01R33/56; G01R33/5601; A; A61; A61K; A61K49/00; A61K49/06; A61K49/20; C; C07; C07D; C07D207/00; C07D207/46; C07D211/00; C07D211/92; C07D211/94; Y; Y10; Y10T; Y10T436/00; Y10T436/24
Claims Analysis
Total Claims: 30
Claim 1
Independent Claim
235 words
A method of enhancing the image obtained by NMR scanning of an organ associated with the cardiovascular system of a human being which comprises injecting into the blood of the human being, prior to the NMR scan on the organ, in admixture with a non-toxic injectable pharmacologically acceptable aqueous vehicle, an amount which is both nontoxic and effective to reduce the relaxation time of the blood during the scanning period sufficiently to enhance the NMR image produced by the scan of a charged, stable organic nitroxide of the formula: ##STR8## wherein R 1 , and R 4 each are alkyl or hydroxyalkyl of 1-4 carbon atoms; R 2 and R 3 each are alkyl, hydroxyalkyl of 1-4 carbons or --alk--R', in which alk is alkylene of 1-8 carbon atoms and R' is R as defined below, --NH 2 , --NHR 1 , or --NR 1 R 2 , in which R 1 and R 2 are alkyl or hydroxyalkyl of 1-4 carbon atoms; and R is --alk--COO - M + or --B--N + (Alk) 3 Hal in which alk is as defined above, B is a divalent bond or alk as defined above and M + is an ammonium or metal ion, Alk is alkyl of 1-8 carbon atoms or a corresponding alkyl group substituted by a free or esterified hydroxy group, and Hal - is Cl - , Br - or I - .
Claim 2
Independent Claim
235 words
A method of enhancing the image obtained by NMR scanning of an organ associated with the cardiovascular system of a human being which comprises injecting into the blood of the human being, prior to the NMR scan on the organ, in admixture with a non-toxic injectable pharmacologically acceptable aqueous vehicle, an amount which is both nontoxic and effective to reduce the relaxation time of the blood during the scanning period sufficiently to enhance the NMR image produced by the scan of a charged, stable organic nitroxide of the formula: ##STR8## wherein R 1 , and R 4 each are alkyl or hydroxyalkyl of 1-4 carbon atoms; R 2 and R 3 each are alkyl, hydroxyalkyl of 1-4 carbons or --alk--R', in which alk is alkylene of 1-8 carbon atoms and R' is R as defined below, --NH 2 , --NHR 1 , or --NR 1 R 2 , in which R 1 and R 2 are alkyl or hydroxyalkyl of 1-4 carbon atoms; and R is --alk--COO - M + or --B--N + (Alk) 3 Hal in which alk is as defined above, B is a divalent bond or alk as defined above and M + is an ammonium or metal ion, Alk is alkyl of 1-8 carbon atoms or a corresponding alkyl group substituted by a free or esterified hydroxy group, and Hal - is Cl - , Br - or I - .
Claim 3
Dependent Claim
18 words
A method according to claim 1, wherein R is --B--N + (Alk) 3 Hal - as defined therein.
Claim 4
Dependent Claim
41 words
A method according to claim 2, wherein R 1 , R 2 , R 3 and R 4 each are CH 3 wherein B is alkylene of 1-4 carbon atoms and wherein Alk is alkyl of 1 to 4 carbon atoms.
Claim 5
Dependent Claim
40 words
A method according to claim 2, wherein R 1 , R 2 , R 3 and R 4 each are CH 3 , wherein B is a divalent bond and wherein Alk is alkyl of 1 to 4 carbon atoms.
Claim 6
Dependent Claim
12 words
A method according to claim 1, wherein the nitroxide is 3-(N,N,N-dimethylethylamino)-2,2,5,5-tetramethylpyrrolidin-1-oxyl iodide.
Claim 7
Dependent Claim
16 words
A method according to claim 1, wherein R is --alk--COO - M + as defined therein.
Claim 8
Dependent Claim
23 words
A method according to claim 6, wherein R 1 , R 2 , R 3 and R 4 each are CH 3 .
Claim 9
Dependent Claim
33 words
A method according to claim 6, wherein R 1 , R 2 , R 3 and R 4 each are CH 3 , and M + is Na + or K + .
Claim 10
Dependent Claim
15 words
A method according to claim 1, wherein the nitroxide is the sodium salt of 2,2,5,5l-tetramethyl-3l-(1'-carboxy-propyl-2')pyrrolidyl-1-oxy.
Claim 11
Independent Claim
221 words
A method of enhancing the image obtained by NMR scanning of the joint of an animal which comprises injecting into the joint of the animal, prior to the NMR scan on the joint, in admixture with a non-toxic injectable pharmacologically acceptable aqueous vehicle, an amount which is both non-toxic and effective to enhance the NMR image produced by the scan of a neurologically acceptable and nontoxic charged, stable organic nitroxide of the formula: ##STR9## wherein R 1 , and R 4 each are alkyl or hydroxyalkyl of 1-4 carbon atoms; R 2 and R 3 each are alkyl, hydroxyalkyl of 1-4 carbons or --alk--R', in which alk is alkylene of 1-8 carbon atoms and R' is R as defined below, --NH 2 , --NHR 1 , or --NR 1 R 2 , in which R 1 and R 2 each are alkyl or hydroxyalkyl of 1-4 carbon atoms; and R is --alk--COO - M + or --B--N + (Alk) 3 Hal - in which alk is as defined above, B is a divalent bond or alk as defined above and M + is an ammonium or metal ion, Alk is alkyl of 1-8 carbon atoms or a corresponding alkyl group substituted by a free or esterified hydroxy group, and Hal - is Cl - , Br - or I - .
Claim 12
Independent Claim
221 words
A method of enhancing the image obtained by NMR scanning of the joint of an animal which comprises injecting into the joint of the animal, prior to the NMR scan on the joint, in admixture with a non-toxic injectable pharmacologically acceptable aqueous vehicle, an amount which is both non-toxic and effective to enhance the NMR image produced by the scan of a neurologically acceptable and nontoxic charged, stable organic nitroxide of the formula: ##STR9## wherein R 1 , and R 4 each are alkyl or hydroxyalkyl of 1-4 carbon atoms; R 2 and R 3 each are alkyl, hydroxyalkyl of 1-4 carbons or --alk--R', in which alk is alkylene of 1-8 carbon atoms and R' is R as defined below, --NH 2 , --NHR 1 , or --NR 1 R 2 , in which R 1 and R 2 each are alkyl or hydroxyalkyl of 1-4 carbon atoms; and R is --alk--COO - M + or --B--N + (Alk) 3 Hal - in which alk is as defined above, B is a divalent bond or alk as defined above and M + is an ammonium or metal ion, Alk is alkyl of 1-8 carbon atoms or a corresponding alkyl group substituted by a free or esterified hydroxy group, and Hal - is Cl - , Br - or I - .
Claim 13
Dependent Claim
18 words
A method according to claim 10, wherein R is --B--N + (Alk) 3 Hal - as defined therein.
Claim 14
Dependent Claim
43 words
A method according to claim 1, wherein R 1 , R 2 , R 3 and R 4 each are CH 3 , wherein B is alkylene of 1 to 4 carbon atoms and Alk is alkyl of 1 to 4 carbon atoms.
Claim 15
Dependent Claim
40 words
A method according to claim 1, wherein R 1 , R 2 , R 3 and R 4 each are CH 3 , wherein B is a divalent bond and wherein Alk is alkyl of 1 to 4 carbon atoms.
Claim 16
Dependent Claim
12 words
A method according to claim 10, wherein the nitroxide is 3-(N,N,N-dimethylethylamino)-2,2,5,5-tetramethylpyrrolidin-1-oxyl iodide.
Claim 17
Dependent Claim
16 words
A method according to claim 10, wherein R is --alk--COO - M + as defined therein.
Claim 18
Dependent Claim
23 words
A method according to claim 15, wherein R 1 , R 2 , R 3 and R 4 each are CH 3 .
Claim 19
Dependent Claim
33 words
A method according to claim 15, wherein R 1 , R 2 , R 3 and R 4 each are CH 3 , and M + is Na + or K + .
Claim 20
Dependent Claim
15 words
A method according to claim 10, wherein the nitroxide is the sodium salt of 2,2,5,5-tetramethyl-3-(1'-carboxy-propyl-2')pyrrolidyl-1-oxy.
Claim 21
Dependent Claim
191 words
A pharmaceutical composition adapted for injection into the blood intravenously or into the joint of a human being comprising per unit dosage amount a non-toxic NMR image enhancing amount in a sterile solution vehicle of a charged, stable organic nitroxide of the formula ##STR10## wherein R 1 , and R 4 each are alkyl or hydroxyalkyl of 1-4 carbon atoms; R 2 and R 3 each are alkyl, hydroxyalkyl of 1-4 carbons or --alk--R', in which alk is alkylene of 1-8 carbon atoms and R' is R as defined below, --NH 2 , --NHR 1 , or --NR 1 R 2 , in which R 1 and R 2 each are alkyl or hydroxyalkyl of 1-4 carbon atoms; and R is --alk--COO - M + or --B--N + (Alk) 3 Hal - in which alk is as defined above, B is a divalent bond or alk as defined above and M + is an ammonium or metal ion, Alk is alkyl of 1-8 carbon atoms or a corresponding alkyl group substituted by a free or esterified hydroxy group, and Hal - is Cl - , Br - or I - .
Claim 22
Dependent Claim
191 words
A pharmaceutical composition adapted for injection into the blood intravenously or into the joint of a human being comprising per unit dosage amount a non-toxic NMR image enhancing amount in a sterile solution vehicle of a charged, stable organic nitroxide of the formula ##STR10## wherein R 1 , and R 4 each are alkyl or hydroxyalkyl of 1-4 carbon atoms; R 2 and R 3 each are alkyl, hydroxyalkyl of 1-4 carbons or --alk--R', in which alk is alkylene of 1-8 carbon atoms and R' is R as defined below, --NH 2 , --NHR 1 , or --NR 1 R 2 , in which R 1 and R 2 each are alkyl or hydroxyalkyl of 1-4 carbon atoms; and R is --alk--COO - M + or --B--N + (Alk) 3 Hal - in which alk is as defined above, B is a divalent bond or alk as defined above and M + is an ammonium or metal ion, Alk is alkyl of 1-8 carbon atoms or a corresponding alkyl group substituted by a free or esterified hydroxy group, and Hal - is Cl - , Br - or I - .
Claim 23
Dependent Claim
18 words
A composition according to claim 19, wherein R is --B--N + (Alk) 3 Hal - as defined therein.
Claim 24
Dependent Claim
43 words
A composition according to claim 20, wherein R 1 , R 2 , R 3 and R 4 each are CH 3 wherein B is alkylene of 1 to 4 carbon atoms and wherein Alk is alkyl of 1 to 4 carbon atoms.
Claim 25
Dependent Claim
40 words
A composition according to claim 19, wherein R 1 , R 2 , R 3 and R 4 each are CH 3 , wherein B is a divalent bond, and wherein Alk is alkyl of 1 to 4 carbon atoms.
Claim 26
Dependent Claim
12 words
A composition according to claim 19, wherein the nitroxide is 3-(N,N,N-dimethylethylamino)-2,2,5,5-tetramethylpyrrolidin-1-oxyl iodide.
Claim 27
Dependent Claim
16 words
A composition according to claim 19, wherein R is --alk--COO - M + as defined therein.
Claim 28
Dependent Claim
23 words
A composition according to claim 24, wherein R 1 , R 2 , R 3 and R 4 each are CH 3 .
Claim 29
Dependent Claim
41 words
A composition according to claim 24, wherein R 1 , R 2 , R 3 and R 4 each are CH 3 , wherein B is alkylene of 2-4 carbon atoms and M + is Na + or K + .
Claim 30
Dependent Claim
15 words
A composition according to claim 19, wherein the nitroxide is the sodium salt of 2,2,5,5l-tetramethyl-3-(1'-carboxy-propyl-2')pyrrolidyl-1-oxy.
References Cited (Backward Citations)
US3502692A
Cited
US4656026A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-04-14 | 1995-10-14 | 1996-04-14 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-04-14 | 1999-10-14 | 2000-04-14 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-04-14 | 2003-10-14 | 2004-04-14 | $7700.00 | Window Closed / Lapsed |